Seruga B - Search Results

1

Impact of comorbidity on the outcome in men with advanced prostate cancer treated with docetaxel.

Zist A, Amir E, Ocana AF, Seruga B. Zist A, et al. Among authors: seruga b. Radiol Oncol. 2015 Nov 27;49(4):402-8. doi: 10.1515/raon-2015-0038. eCollection 2015 Dec. Radiol Oncol. 2015. PMID: 26834528 Free PMC article.

2

Lapatinib plus paclitaxel as first-line therapy for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: inappropriate conclusions from a company-sponsored study?

Amir E, Seruga B, Freedman O, Tannock I. Amir E, et al. Among authors: seruga b. J Clin Oncol. 2009 Apr 10;27(11):1919; author reply 1920-1. doi: 10.1200/JCO.2008.21.2951. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255302 No abstract available.

3

Amenorrhoea, menopause, and endocrine therapy for breast cancer.

Amir E, Seruga B, Freedman O, Clemons M. Amir E, et al. Among authors: seruga b. BMJ. 2009 Dec 3;339:b4261. doi: 10.1136/bmj.b4261. BMJ. 2009. PMID: 19959583 No abstract available.

4

Treatment of lung cancer.

Seruga B, Amir E, Tannock I. Seruga B, et al. N Engl J Med. 2009 Dec 17;361(25):2485; author reply 2486-7. N Engl J Med. 2009. PMID: 20050212 No abstract available.

5

Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer.

Amir E, Ocaña A, Seruga B, Freedman O, Clemons M. Amir E, et al. Among authors: seruga b. Cancer Treat Rev. 2010 Aug;36(5):410-5. doi: 10.1016/j.ctrv.2009.12.012. Epub 2010 Jan 25. Cancer Treat Rev. 2010. PMID: 20100635 Review.

6

Chemotherapy: dose-dense treatment for triple-negative breast cancer.

Amir E, Ocana A, Freedman O, Clemons M, Seruga B. Amir E, et al. Among authors: seruga b. Nat Rev Clin Oncol. 2010 Feb;7(2):79-80. doi: 10.1038/nrclinonc.2009.231. Nat Rev Clin Oncol. 2010. PMID: 20118978 No abstract available.

7

Medical oncology: Zoledronic acid for breast cancer therapy-induced bone loss.

Amir E, Ocaña A, Seruga B, Josse R, Clemons M. Amir E, et al. Among authors: seruga b. Nat Rev Clin Oncol. 2010 Apr;7(4):187-8. doi: 10.1038/nrclinonc.2010.19. Nat Rev Clin Oncol. 2010. PMID: 20354540

8

Targeting DNA repair in breast cancer: a clinical and translational update.

Amir E, Seruga B, Serrano R, Ocana A. Amir E, et al. Among authors: seruga b. Cancer Treat Rev. 2010 Nov;36(7):557-65. doi: 10.1016/j.ctrv.2010.03.006. Epub 2010 Apr 10. Cancer Treat Rev. 2010. PMID: 20385443 Review.

9

Assessing women at high risk of breast cancer: a review of risk assessment models.

Amir E, Freedman OC, Seruga B, Evans DG. Amir E, et al. Among authors: seruga b. J Natl Cancer Inst. 2010 May 19;102(10):680-91. doi: 10.1093/jnci/djq088. Epub 2010 Apr 28. J Natl Cancer Inst. 2010. PMID: 20427433 Review.

10

Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis.

Seruga B, Amir E. Seruga B, et al. Breast Cancer Res Treat. 2010 Aug;122(3):609-17. doi: 10.1007/s10549-010-0902-3. Epub 2010 May 8. Breast Cancer Res Treat. 2010. PMID: 20454926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters